Voelcker Fund awards $650,000 to cancer researchers on the rise
June 9, 2020
The Max and Minnie Tomerlin Voelcker Fund supports innovative cancer research projects conducted by rising star faculty members.
Stroke bleeds in the brain not decreasing, study finds
June 9, 2020
Brain bleeds called intracerebral hemorrhages remained stable in incidence among all age groups over the past 30 years, but they increased in people 75 and older, according to a new analysis of the Framingham Heart Study.
Researchers pinpoint a protein that may predict untreatable kidney cancer
June 4, 2020
A team of researchers confirmed the role of a certain protein in the development of high-grade kidney cancer. The researchers also showed that a higher level of the protein can be used as a marker to predict which tumors will develop treatment resistance and progress more rapidly.
Risk of death twice as high among cancer patients with COVID-19
May 29, 2020
Mays Cancer Center faculty members authored the data analysis involving more than 900 cancer patients.
Cancer drugs cause large cells that resist treatment; scientist aims to stop it
May 28, 2020
Fueled by genetic changes due to cancer therapy itself, rogue cells may become very large with twice or quadruple the number of chromosomes found in healthy cells. Dr. Daruka Mahadevan, of the Mays Cancer Center, seeks to find drugs that prevent or treat this problem.
Results published of remdesivir, COVID-19 trial
May 28, 2020
According to the study, the drug improved recovery time and decreased the number of deaths.
